Development of a Nutrigenetic Test for Personalized Prescription of Body Weight Loss Diets (Obekit)
Obekit
1 other identifier
interventional
260
1 country
1
Brief Summary
This study evaluates the relationship between several genetic variants and the response to a hypocaloric diet, in order to design a genetic test which permits prescribe the more personalized diet for each individual according to her genotype. Half of the participants will assigned to a moderate high protein diet, while the other half will assigned to a high carbohydrate diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 10, 2016
CompletedFirst Posted
Study publicly available on registry
April 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedMarch 29, 2017
November 1, 2015
2.1 years
March 10, 2016
March 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in body weight at Week 16
Baseline and 16 Weeks
Change in body weight at Week 40
16 Weeks and 40 Weeks
Secondary Outcomes (92)
Height
Baseline
Change in waist and hip circumferences at 16 Weeks
Baseline and 16 Weeks
Change in waist and hip circumferences at 40 Weeks
16 Weeks and 40 Weeks
Change in body fat mass at 16 Weeks
Baseline and 16 Weeks
Change in body fat mass at 40 Weeks
16 Weeks and 40 Weeks
- +87 more secondary outcomes
Study Arms (2)
Moderately high protein diet
EXPERIMENTALCaloric restriction (-30% total energy intake) Macronutrient distribution: 40% of the energy derived from carbohydrates, 30% of the energy derived from protein and 30% of the energy derived from fat
Low fat diet
PLACEBO COMPARATORCaloric restriction (-30% total energy intake) Macronutrient distribution: 60% of the energy derived from carbohydrates, 18% of the energy derived from protein and 22% of the energy derived from fat
Interventions
After the recruitment randomization of the study participants, the study will consists of a 4-month nutritional intervention ("body weight loss period") followed by a second 6-month period ("body weight maintenance period") in which the subjects of the study will continue with the assigned diet, but without any energy restriction.
After the recruitment randomization of the study participants, the study will consists of a 4-month nutritional intervention ("body weight loss period") followed by a second 6-month period ("body weight maintenance period") in which the subjects of the study will continue with the assigned diet, but without any energy restriction.the energy derived from fat
Eligibility Criteria
You may qualify if:
- Body Mass Index (BMI) between 25 and 40 kg/m2
- Physical examination and vital signs normal, or is considered abnormal, but clinically insignificant by researcher.
You may not qualify if:
- BMI less than 25 or higher than 40 kg/m2
- Pregnant women
- Breastfeeding period. If artificial feeding until 6 months after birth.
- Type 1 diabetes
- Severe kidney diseases
- Severe digestive system diseases
- Electrolyte disorders (disorders of sodium, potassium, calcium, chlorine, phosphorus, magnesium)
- Acute cardiovascular diseases
- Cancer
- Anemia
- Eating disorders
- Recent prescription drug treatment (without stable doses scheduled)
- Drug therapy that can influence weight loss as corticosteroids.
- Some type of cognitive impairment and / psychic
- Subjects in which poor collaboration or, in the investigator's opinion, have difficulty following the procedures of the study is foreseen
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Nutrition Research, University of Navarra
Pamplona, Navarre, 31008, Spain
Related Publications (5)
Garcia-Alvarez NC, Riezu-Boj JI, Martinez JA, Garcia-Calzon S, Milagro FI. A Predictive Tool Based on DNA Methylation Data for Personalized Weight Loss through Different Dietary Strategies: A Pilot Study. Nutrients. 2023 Dec 6;15(24):5023. doi: 10.3390/nu15245023.
PMID: 38140282DERIVEDCuevas-Sierra A, Milagro FI, Guruceaga E, Cuervo M, Goni L, Garcia-Granero M, Martinez JA, Riezu-Boj JI. A weight-loss model based on baseline microbiota and genetic scores for selection of dietary treatments in overweight and obese population. Clin Nutr. 2022 Aug;41(8):1712-1723. doi: 10.1016/j.clnu.2022.06.008. Epub 2022 Jun 16.
PMID: 35777110DERIVEDCuevas-Sierra A, Romo-Hualde A, Aranaz P, Goni L, Cuervo M, Martinez JA, Milagro FI, Riezu-Boj JI. Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention. Eur J Nutr. 2021 Sep;60(6):3279-3301. doi: 10.1007/s00394-021-02508-0. Epub 2021 Feb 16.
PMID: 33591390DERIVEDRamos-Lopez O, Cuervo M, Goni L, Milagro FI, Riezu-Boj JI, Martinez JA. Modeling of an integrative prototype based on genetic, phenotypic, and environmental information for personalized prescription of energy-restricted diets in overweight/obese subjects. Am J Clin Nutr. 2020 Feb 1;111(2):459-470. doi: 10.1093/ajcn/nqz286.
PMID: 31751449DERIVEDRamos-Lopez O, Riezu-Boj JI, Milagro FI, Goni L, Cuervo M, Martinez JA. Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight/obese subjects. Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):165-172. doi: 10.1016/j.numecd.2017.11.006. Epub 2017 Dec 5.
PMID: 29331538DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J. Alfredo Martínez, MD, PhD
Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain
- PRINCIPAL INVESTIGATOR
Fernando J. Corrales, PhD
CIMA, University of Navarra
- STUDY CHAIR
Femín I Milagro, PhD
Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain
- STUDY CHAIR
Jose Ignacio Riezu, PhD
Centre for Nutrition Research, University of Navarra
- STUDY CHAIR
Carlos González-Navarro, PhD
Centre for Nutrition Research, University of Navarra
- STUDY CHAIR
Marta Cuervo, PhD
Centre for Nutrition Research, University of Navarra
- STUDY CHAIR
Iosune Zubieta
Centre for Nutrition Research, University of Navarra
- STUDY CHAIR
Blanca Esther Martínez de Morentin, MD
Centre for Nutrition Research, University of Navarra
- STUDY CHAIR
Leticia Goñi
Centre for Nutrition Research, University of Navarra
- STUDY CHAIR
Santiago Navas, PhD
Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2016
First Posted
April 13, 2016
Study Start
November 1, 2015
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
March 29, 2017
Record last verified: 2015-11
Data Sharing
- IPD Sharing
- Will not share